8.1 KDIGO AKI Classification, Etiologies & Diagnostic Evaluation

Diagnostic Framework and KDIGO Staging

Acute kidney injury (AKI) affects over 50% of critically ill intensive care unit (ICU) patients and represents an independent predictor of short- and long-term mortality, cardiovascular events, prolonged mechanical ventilation, and transition to end-stage kidney disease (ESKD). Historical diagnostic frameworks, including the RIFLE (Risk, Injury, Failure, Loss of kidney function, End-stage kidney disease) criteria (2004) and the Acute Kidney Injury Network (AKIN) criteria (2007), standardized the definition of acute renal dysfunction. In 2012, the Kidney Disease: Improving Global Outcomes (KDIGO) consensus guideline synthesized these systems into a unified, globally adopted definition and staging framework.

KDIGO Diagnostic Definition

Under KDIGO criteria, AKI is definitively established by the presence of any one of the following:

1. An absolute increase in serum creatinine (SCr) by $\ge 0.3\text{ mg/dL}$ ($\ge 26.5\ \mu\text{mol/L}$) within a 48-hour window; or
2. A documented or presumed increase in SCr to $\ge 1.5\times$ baseline within the preceding 7 days; or
3. An hourly urine output (UOP) $< 0.5\text{ mL/kg/h}$ for at least 6 consecutive hours.

KDIGO Severity Staging

Once AKI is diagnosed, severity is stratified across three progressive stages based on the maximum degree of serum creatinine elevation or the duration and severity of oliguria. When creatinine and urine output parameters yield discordant stages, the higher (more severe) stage dictates classification:

Clinical Nuances of Biomarker Kinetics in the ICU

Serum creatinine is an imperfect surrogate of acute changes in glomerular filtration rate. Creatinine is a steady-state kinetic marker: following an abrupt, complete cessation of bilateral renal filtration, serum creatinine rises at an absolute rate of approximately $1.0\text{ to }1.5\text{ mg/dL per day}$. Consequently, a patient with fulminant septic shock and bilateral renal cortical necrosis may maintain a normal serum creatinine for the initial 24 to 48 hours. Conversely, hourly urine output changes instantaneously in response to hemodynamic collapse, sympathetic activation, and neurohormonal tone, making oliguria the earlier and more sensitive marker of injury in monitored ICU patients.

Furthermore, aggressive crystalloid fluid resuscitation induces significant fluid overload and hemodilution, which artificially depresses measured serum creatinine concentrations. Clinicians should calculate adjusted serum creatinine using cumulative fluid balance to avoid under-recognizing AKI:

$\text{Adjusted SCr} = \text{Measured SCr} \times \left(1 + \frac{\text{Cumulative Net Fluid Balance (L)}}{\text{Total Body Water (L)}}\right)$

Where total body water is estimated as $0.6\times\text{weight (kg)}$ in non-elderly males and $0.5\times\text{weight (kg)}$ in non-elderly females.

---

Etiological Taxonomy: Pre-Renal, Intrinsic, and Post-Renal

Determining the root cause of acute renal failure dictates therapeutic management. Etiologies are traditionally partitioned into three broad pathophysiological compartments:

Loading diagram...

1. Pre-Renal Azotemia (Functional Hypoperfusion)

Pre-renal azotemia arises when renal parenchymal integrity is entirely preserved, but diminished renal blood flow compromises the glomerular filtration pressure gradient. Causes fall into three functional subsets:

• True Intravascular Hypovolemia: Massive blood loss, gastrointestinal losses (severe vomiting, secretory diarrhea), insensible cutaneous losses (severe burns, toxic epidermal necrolysis), or profound unreplaced urinary losses (diabetic ketoacidosis, hyperosmolar hyperglycemic state).
• Decreased Effective Circulating Arterial Volume (ECAV): Systemic arterial underfilling despite total body fluid overload, seen characteristically in acute decompensated heart failure with low cardiac index (cardiorenal syndrome Type 1), end-stage hepatic cirrhosis with splanchnic arterial vasodilation (hepatorenal syndrome Type 1 / HRS-AKI), and distributive septic vasodilation.
• Disrupted Intrarenal Autoregulation: Normal autoregulatory mechanisms maintain glomerular capillary hydraulic pressure ($P_{\text{gc}}$) across mean arterial pressures ranging from 65 to 110 mmHg via afferent arteriolar vasodilation (mediated by local prostaglandins and nitric oxide) and efferent arteriolar vasoconstriction (mediated by angiotensin II):
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs): Inhibit cyclooxygenase-1 and -2, abolishing vasodilatory prostaglandin ($PGE_2, PGI_2$) synthesis at the afferent arteriole. The afferent arteriole constricts, precipitating an acute fall in $P_{\text{gc}}$.
  • Angiotensin-Converting Enzyme Inhibitors (ACEis) and Angiotensin Receptor Blockers (ARBs): Inhibit angiotensin II-mediated efferent arteriolar vasoconstriction. The efferent arteriole dilates, depressurizing the glomerular capillary tuft and dropping GFR.
  • Calcineurin Inhibitors (Tacrolimus, Cyclosporine): Induce severe, dose-dependent afferent arteriolar vasoconstriction.

2. Intrinsic Acute Kidney Injury (Parenchymal Damage)

Intrinsic AKI involves structural and cellular injury localized to the renal tubules, interstitium, glomeruli, or renal microvasculature:

• Acute Tubular Necrosis (ATN): Accounts for $> 80\%$ of intrinsic AKI cases in the ICU.
  • Ischemic ATN: Follows prolonged, uncorrected pre-renal hypoperfusion, severe septic shock, sustained intraoperative hypotension, or cardiopulmonary bypass. The medullary thick ascending limb of the loop of Henle and the S3 segment of the proximal tubule suffer marked hypoxic necrosis due to baseline high metabolic activity and tenuous medullary oxygen delivery.
  • Nephrotoxic ATN: Direct cellular injury from exogenous toxins (aminoglycosides, IV iodinated radiocontrast agents, vancomycin, amphotericin B, cisplatin, polymyxins) or endogenous pigment nephropathy (myoglobin in rhabdomyolysis, hemoglobin in massive intravascular hemolysis, or Bence-Jones light-chain cast nephropathy in multiple myeloma).
• Acute Interstitial Nephritis (AIN): An immune-mediated hypersensitivity reaction confined to the renal tubulointerstitium. Classically triggered by medications ($> 75\%$ of cases), notably beta-lactam antibiotics, cephalosporins, fluoroquinolones, proton pump inhibitors (PPIs), NSAIDs, and sulfonamides. Less commonly driven by autoimmune conditions (sarcoidosis, systemic lupus erythematosus [SLE], Sjögren's syndrome) or systemic infections (Legionella, CMV, EBV). The traditional clinical triad of fever, maculopapular rash, and peripheral eosinophilia is present in $< 10\text{ to }15\%$ of biopsy-confirmed cases; microscopic pyuria and WBC casts are far more reliable.
• Acute Glomerulonephritis (GN) and Systemic Vasculitis: Rapidly progressive glomerulonephritis (RPGN) characterized by immune crescent formation. Subdivided into: Pauci-immune ANCA-associated vasculitis (granulomatosis with polyangiitis, microscopic polyangiitis); Anti-glomerular basement membrane (anti-GBM / Goodpasture) disease; and Immune complex GN (lupus nephritis, post-streptococcal GN, cryoglobulinemia, IgA nephropathy).
• Renal Microvascular Disease: Atheroembolic renal disease (cholesterol crystal embolization following endovascular or angiographic manipulation, presenting with livedo reticularis, blue toe syndrome, transient eosinophilia, and hypocomplementemia), thrombotic microangiopathy (TMA / TTP / atypical HUS), and acute renal cortical necrosis.

3. Post-Renal (Obstructive) Nephropathy

Mechanical impedance to urine outflow, which increases intra-tubular hydrostatic pressure, counteracts glomerular filtration, and incites medullary vasoconstriction. Obstruction may occur at the urethral/prostatic level (benign prostatic hyperplasia, obstructive Foley catheter, neurogenic bladder) or bilaterally at the ureteral level (retroperitoneal fibrosis, pelvic or retroperitoneal malignancies, bilateral nephrolithiasis, or unilateral obstruction in a solitary functioning kidney).

---

Diagnostic Evaluation: Urine Microscopy and Biomarkers

A disciplined diagnostic sequence distinguishes pre-renal physiology from intrinsic tubular injury, guiding fluid therapy versus dialytic preparation.

Urinalysis and Sediment Microscopy

Bedside urine sediment examination performed by the intensivist represents a non-invasive optical biopsy of the kidney:

Loading diagram...

• Muddy Brown Granular Casts: Sloughed, degenerate tubular epithelial cells fused with Tamm-Horsfall mucoprotein. Pathognomonic for ischemic or nephrotoxic ATN.
• Renal Tubular Epithelial (RTE) Cells and RTE Casts: Indicate direct, active necrotizing tubular cell death.
• Red Blood Cell (RBC) Casts and Acanthocytes (Dysmorphic RBCs): Pathognomonic for glomerular rupture and active proliferative glomerulonephritis or small-vessel vasculitis.
• White Blood Cell (WBC) Casts and Pyuria: In the absence of urinary tract infection, diagnostic of interstitial inflammation (acute interstitial nephritis).
• Broad, Waxy Casts: Reflect broad-caliber tubular dilation and stasis, pathognomonic for chronic kidney disease (CKD) rather than isolated hyperacute injury.
• Urine Dipstick Discrepancy in Rhabdomyolysis: The orthotolidine reagent on the urine test strip cross-reacts with the heme moiety of both myoglobin and hemoglobin. When the dipstick shows $3+\text{ to }4+$ blood but microscopic sediment examination reveals zero to rare intact red blood cells, pigment nephropathy (rhabdomyolysis or intravascular hemolysis) is confirmed.

Fractional Excretion Indices: $FENa$ vs. $FEUrea$

1. Fractional Excretion of Sodium ($FENa$)

The $FENa$ quantifies the percentage of sodium filtered by the glomeruli that escapes tubular reabsorption and appears in the urine:

$FENa = \frac{U_{\text{Na}} \times P_{\text{Cr}}}{P_{\text{Na}} \times U_{\text{Cr}}} \times 100\%$

• In pre-renal azotemia, intact renal tubules maximally reabsorb sodium and water under intense aldosterone and angiotensin II stimulation: $FENa < 1\%$ (often $< 0.1\%$), and urine sodium concentration ($U_{\text{Na}}$) is typically $< 20\text{ mEq/L}$.
• In established ATN, damaged tubular epithelial cells lose their active $\text{Na}^+/\text{K}^+$-ATPase basolateral polarity, causing obligatory natriuresis: $FENa > 2\%$ and $U_{\text{Na}} > 40\text{ mEq/L}$.

2. Fractional Excretion of Urea ($FEUrea$)

Urea reabsorption occurs passively in the proximal convoluted tubule and inner medullary collecting duct along with water and sodium, independent of the thick ascending limb. Loop and thiazide diuretics do not directly inhibit proximal tubular urea reabsorption. Therefore, the fractional excretion of urea ($FEUrea$) is the index of choice when a patient has received diuretics within the previous 24 to 48 hours:

$FEUrea = \frac{U_{\text{Urea}} \times P_{\text{Cr}}}{P_{\text{Urea}} \times U_{\text{Cr}}} \times 100\%$

• $FEUrea < 35\%$: Establishes pre-renal azotemia, even in the presence of active loop diuresis.
• $FEUrea > 50\%$: Diagnostic of acute tubular necrosis.

Comprehensive Comparison of Diagnostic Urinary Indices

---

Renal Ultrasonography and Dynamic Assessment

Bedside Renal Ultrasonography

Ultrasound should be performed promptly in unexplained AKI to evaluate three critical anatomical domains:

1. Hydronephrosis (Obstruction): Dilation of the renal pelvis and calyces establishes post-renal obstruction. However, false-negative ultrasounds (absence of pelvic dilation despite true obstruction) occur in:
   • Early acute obstruction ($< 24\text{ to }48\text{ hours}$ before calyces dilate);
   • Severe intravascular volume depletion / hypovolemia (insufficient urinary volume to distend the collecting system);
   • Retroperitoneal fibrosis or retroperitoneal tumor encasement physically encasing the ureters and preventing radial expansion.
2. Renal Cortical Echogenicity: Normal renal parenchyma is hypoechoic relative to normal liver or spleen parenchyma. Increased parenchymal echogenicity (equal to or greater than liver) indicates medical renal parenchymal disease (diffuse intrinsic injury or glomerulonephritis).
3. Renal Dimensions: Normal bipolar renal length is $10\text{ to }12\text{ cm}$. Small, contracted kidneys ($< 9\text{ cm}$) with cortical thinning ($< 1\text{ cm}$) identify pre-existing chronic kidney disease. Conversely, enlarged, edematous kidneys may be seen in acute glomerulonephritis, severe AIN, amyloidosis, HIV nephropathy, and acute renal vein thrombosis.

The Furosemide Stress Test (FST)

The Furosemide Stress Test is a validated, dynamic bedside challenge of functional medullary tubular integrity in non-anuric, volume-resuscitated critically ill patients with KDIGO Stage 1 or 2 AKI.

Loading diagram...

• Physiological Basis: Furosemide is highly protein-bound ($> 95\%$) and enters the tubular lumen almost exclusively via active transport by organic acid transporters (OAT-1, OAT-3) in the proximal convoluted tubule. Once inside the lumen, it must travel down to the thick ascending limb of Henle and bind the $\text{Na}^+-\text{K}^+-2\text{Cl}^-$ co-transporter to block sodium reabsorption and trigger natriuretic diuresis. A brisk diuretic response demonstrates preserved proximal secretion, patent tubular lumens, and functional thick ascending limb epithelium.
• Protocol:
  • Confirm that the patient is strictly euvolemic or fluid replete (never perform an FST in a hypovolemic patient);
  • Administer an intravenous bolus of furosemide: $1.0\text{ mg/kg}$ for loop-diuretic naive patients, or $1.5\text{ mg/kg}$ for patients with prior chronic loop diuretic exposure;
  • Replace hourly urinary output milliliter-for-milliliter with balanced crystalloid (e.g., Plasma-Lyte or Lactated Ringer's) for the duration of the test if the patient is not hypervolemic, to avoid inducing hypovolemia.
• Interpretation: A cumulative urine output $< 200\text{ mL}$ over the first 2 hours post-administration constitutes a failed test. It predicts progression to KDIGO Stage 3 AKI and the need for renal replacement therapy with a sensitivity of about $87\%$ and specificity of about $84\%$ (Chawla et al., 2013), and it compared favorably with static novel biomarkers (such as urinary NGAL, KIM-1, or TIMP-2 $\times$ IGFBP7).